FdaApplication
ANDA 208972
Identifiers
- fda_app_no: ANDA208972
Properties
| Property | Value |
|---|---|
| applicant_name | EPIC PHARMA LLC |
| application_type | ANDA |
| approval_date | 2019-04-16 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 12.5MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 2.5MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET;ORAL |
7 products